Vanessa Banz
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (15)
Year:
2025
Year:
2025
Year:
2025
Introduction Solid organ transplantation (SOT) is a lifesaving treatment for end‐stage organ failure. Although many factors affect the success of organ transplantation, recipient and donor sex are important biological factors influencing transplant outcome. However, the impact of the four possible recipient and donor sex combinations (RDSC) on transplant outcome remains largely unclear. Methods A scoping review was carried out focusing on studies examining the association between RDSC and outcomes (mortality, graft rejection, and infection) after heart, lung, liver, and kidney transplantation. All studies up to February 2023 were included. Results Multiple studies published between 1998 and 2022 show that RDSC is an important factor affecting the outcome after organ transplantation. Male recipients of SOT have a higher risk of mortality and graft failure than female recipients. Differences regarding the causes of death are observed. Female recipients on the other hand are more susceptible to infections after SOT. Conclusion Differences in underlying illnesses as well as age, immunosuppressive therapy and underlying biological mechanisms among male and female SOT recipients affect the post‐transplant outcome. However, the precise mechanisms influencing the interaction between RDSC and post‐transplant outcome remain largely unclear. A better understanding of how to identify and modulate these factors may improve outcome, which is particularly important in light of the worldwide organ shortage. An analysis for differences of etiology and causes of graft loss or mortality, respectively, is warranted across the RDSC groups. Practitioner points Recipient and donor sex combinations affect outcome after solid organ transplantation. While female recipients are more susceptible to infections after solid organ transplantation, they have higher overall survival following SOT, with causes of death differing from male recipients. Sex‐differences should be taken into account in the post‐transplant management.
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Collaborators (12)
Guido Beldi
Full Professor
University of Bern
Jean-François Dufour
Clinic Director UVCM Hepatology / Head Physician Hepatology
Insel Gruppe AG
Martin D. Berger
-
Christian Toso
Full Professor
University of Geneva
Stefan Schaub
University Hospital Basel
Dionysios Neofytos
University Hospital of Geneva
Déla Golshayan
Associate Professor
University of Lausanne
Stefan Zeuzem
Professor of Medicine
University Hospital
Carlotta Riebensahm
University Hospital of Bern
Nicolas Goossens
Chargé de Cours, Lecturer
University of Geneva
Andrea De Gottardi
-
Jeroen de Jonge
Erasmus University Rotterdam
Make your next move.
Prepare your application
Review drafts before you send them.